Estuary Biotherapeutics Launches with $103 Million to Develop Targeted Gene Therapies for Kidney Disease
For best results when printing this announcement, please click on link below: Estuary Biotherapeutics Launches with $103 Million to Develop Targeted Gene Therapies for Kidney Disease Paradigm-shifting approach targeting the root cause of autosomal dominant polycystic kidney disease (ADPKD), with the goal of durably hal